Compassionate Care Research Group, Inc.

Fountain Valley, California 92866

1 studies enrolling now · 11 studies all time

What they study most

Bile Duct Cancer, Bladder Cancer, Breast Cancer, Cancer and Chemotherapy Related Anemia, Carcinoma, Colorectal, Carcinoma, Non-Small-Cell Lung, Cholangiocarcinoma, Colorectal Cancer, Esophageal Cancer, Gallbladder Cancer, Head and Neck Cancer, Kidney Cancer

Studies at this site

• Development and Analysis of a Stool Bank for Cancer Patients — Recruiting now
• A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients — Recruiting now
• A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM) — Stopped early
• Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors — Stopped early
• SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) — Completed
• SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide — Completed
• Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer® — Completed
• Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer — Completed
• Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma — Completed
• Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients — Stopped early
• Rociletinib (CO-1686) USA Expanded Access Program — NO_LONGER_AVAILABLE